DanielDMikolMDPhD
Neurology • Newbury Park, CAHeadache, Neuroimmunology/Multiple Sclerosis, Neurodegenerative
Physician
Dr. Mikol is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Amgen
1 Amgen Center Drive
Newbury Park, CA 91320- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Neurology, 1993 - 1996
University of ChicagoInternship, Internal Medicine, 1992 - 1993
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1992
Clinical Trials
- Atacicept in Multiple Sclerosis Extension Study, Phase II Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- 9 citationsEfficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase...Koichi Hirata, Fumihiko Sakai, Takao Takeshima, Noboru Imai, Yasuhiko Matsumori, Ryuji Yoshida, Yotaro Numachi, Cheng Peng, Daniel D. Mikol, Sunfa Cheng> ;The Journal of Headache and Pain. 2021 Sep 18
- 3 citationsReduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.David W. Dodick, David Kudrow, Uwe Reuter, Nadia Tenenbaum, Feng Zhang, Gabriel Paiva da Silva Lima, Denise E. Chou, Daniel D. Mikol, Richard B. Lipton> ;Cephalalgia. 2021 Aug 18
- 9 citationsReduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical tri...Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H. Bonner, Hernan Picard, Sunfa Cheng, Denise E. Chou, Feng Zhang, Jan Klatt, Dani...> ;The Journal of Headache and Pain. 2021 Jul 23
- Join now to see all
Journal Articles
- Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes – the Migraine Functional Impact Questionnaire (MFIQ)Daniel D Mikol, Dawn C Buse, Wiley
- A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients with Stable AnginaAmaal Starling, Daniel D Mikol, Headache: The Journal of Head and Face Pain
Press Mentions
NervGen Pharma Announces Completion of Dosing of All Subjects in Phase 1 Clinical Trial of Proprietary Drug Candidate NVG-291February 14th, 2023- NervGen Hosting Panel Discussion with Leading Experts at the 2022 Annual Meeting of American Spinal Cord Injury Association (ASIA)May 16th, 2022
- NervGen Pharma Receives Approval to Proceed to the Final Dose Cohort in Phase 1 Clinical Trial of NVG-291 and Reports Q1 2022 ResultsMay 12th, 2022
- Join now to see all
Grant Support
- Effect Of Body Cooling By RTX On Motor Function In Heat-Sensitive MS PatientsNational Center For Research Resources2007
- Caveolin-1/Lgf-Ir Interactions In OligodendrocytesNational Institute Of Neurological Disorders And Stroke2002–2004
- Oligodendrocyte/Myelin Glycoprotein And The PNational Institute Of Neurological Disorders And Stroke1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
